DISPLACE: Dissemination and Implementation of Stroke Prevention Looking at the Care Environment
DISPLACE:从护理环境来看中风预防的传播和实施
基本信息
- 批准号:9925881
- 负责人:
- 金额:$ 101.54万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-08-01 至 2022-06-30
- 项目状态:已结题
- 来源:
- 关键词:AdoptionAffectAgeAssessment toolBrain InfarctionCaregiversCaringChildChildhoodChronicClinicalClinical DataClinical TrialsClinical Trials DesignCollaborationsCommon Data ElementCommunitiesComplicationComprehensive Health CareComputerized Medical RecordCustomDataDefectDevelopmentDictionaryDiseaseDoppler UltrasoundEducationEducational MaterialsEffectivenessEligibility DeterminationEnrollmentEnsureEnvironmentErythrocytesEvaluationFaceFocus GroupsFundingFutureGenerationsGeographic DistributionGoalsGuidelinesHealthHealthcareHematological DiseaseHematologyHemoglobinIndividualInformation TechnologyInheritedInstitutionInterventionInterviewIschemic StrokeKnowledgeLeadLeadershipMeasuresMedicalMethodsMinorityModelingMorbidity - disease rateMulti-Institutional Clinical TrialMulticenter StudiesNational Heart, Lung, and Blood InstituteOutcomePatient EducationPatient-Focused OutcomesPatientsPopulationPreventionPrevention GuidelinesPrevention ProtocolsPrevention trialPrivate SectorProtocols documentationProviderRandomizedRandomized Clinical TrialsReadinessRecommendationResearchResearch DesignRiskSamplingServicesSickle Cell AnemiaSiteSocioeconomic FactorsSouth CarolinaSpecialistSpecific qualifier valueStandardizationStrokeStroke preventionSurveysSystemThird-Party PayerTimeTransfusionUnited StatesUniversitiesVascular Endotheliumbasecohortcompare effectivenessdata managementdesignevidence baseevidence based guidelineshealth disparityhigh riskhydroxyureaimplementation scienceimplementation strategyimprovedmortalitymultidisciplinarynovelpatient populationpatient screeningpediatric patientsscreeningsocial mediastroke risktreatment strategyweb site
项目摘要
Project Abstract
Ischemic stroke is a potentially preventable, devastating complication of sickle cell disease (SCD), a group of
inherited blood disorders that affect close to 100,000 individuals in the United States. Without intervention,
stroke may occur in up to 24% of individuals with the highest risk form of SCD, sickle cell anemia. Despite
improvements in comprehensive care and management of SCD in children, stroke remains a major cause of
morbidity and mortality due to insufficient screening and prevention practices. Individuals living with SCD
continue to face multiple health disparities cause by racial and socioeconomic factors as well as disease-
specific disparities in funding and private sector support. In order to standardize and improve care, the National
Heart, Lung, and Blood Institute (NHLBI) released evidence-based guidelines in 2014. These guidelines
established routine transcranial Doppler ultrasound (TCD) screening as a means for identifying children at high
risk of stroke and indefinite chronic red cell transfusions (CRCT) as a means of treating children at high risk for
stroke based on the previous NHLBI funded, randomized controlled STOP (Stroke Prevention Trial in Sickle
Cell Disease) results. This proposal, entitled DISPLACE (Dissemination and Implementation of Stroke
Prevention Looking at the Care Environment) is a multi-site effort focused on enhancing the implementation
and dissemination of these evidence-based stroke prevention guidelines in SCD. The research approach is
guided by the Interactive Systems Framework for Dissemination and Implementation and the multilevel
ecological model of health. The DISPLACE leadership core at the Medical University of South Carolina is a
multidisciplinary team lead by Dr. Julie Kanter, Dr. Robert Adams and Dr. Cathy Melvin and includes
specialists in multicenter clinical trial design, hematology, implementation science, qualitative analysis and
statistical evaluation. The Data Coordinating Unit (DCU) at MUSC who have coordinated over 40 multicenter
studies and will provide study design and information technology support and data management support the
leadership core. The aims of DISPLACE are to: 1) assess the gap between current and guideline-
recommended practices for stroke prevention among pediatric patients with SCD, 2) assess the multi-level
patient, provider, and systems barriers and enablers to performing TCD screening and initiating CRCT, and 3)
evaluate the effectiveness of a novel multi-level dissemination and implementation strategy to increase current
annual TCD screening rates and CRCT initiation rates using a parallel cluster-randomized clinical trial. We
have assembled a large, multi-institutional collaboration of institutions with widespread geographic distribution
to best assess the feasibility and utility of the multi-level implementation strategy. The long-term goal of
DISPLACE is to ensure that all children with SCD receive guideline-based care for stroke prevention for a
“stroke free generation” in SCD.
项目摘要
缺血性中风是镰状细胞病(SCD)的一种潜在的可预防的破坏性并发症,一组
遗传性血液疾病在美国影响着近10万人。如果不进行干预,
中风可能发生在高达24%的具有SCD最高风险形式的个人中,即镰状细胞性贫血。尽管
改善儿童SCD的综合护理和管理,中风仍然是主要原因
筛查和预防措施不足造成的发病率和死亡率。患有SCD的个人
继续面临种族和社会经济因素以及疾病造成的多重健康差距--
资金和私营部门支持方面的具体差距。为了规范和改善护理,国家
心、肺和血液研究所(NHLBI)在2014年发布了循证指南。这些指导方针
建立常规经颅多普勒超声(TCD)筛查作为识别高血压病儿童的手段
卒中风险和无限期慢性红细胞输注(CRCT)作为治疗高危儿童的一种手段
基于之前NHLBI资助的随机对照STOP(镰刀卒中预防试验)的卒中
细胞疾病)结果。这项题为《置换(中风的传播和实施)》的提案
预防看护理环境)是一项多地点的努力,重点是加强实施
并在SCD中传播这些循证中风预防指南。研究方法是
在传播和实施的互动系统框架和多层次指导下
健康的生态模式。南卡罗来纳医科大学的置换领导核心是
由朱莉·坎特博士、罗伯特·亚当斯博士和凯西·梅尔文博士领导的多学科团队包括
多中心临床试验设计、血液学、实施科学、定性分析和
统计评估。MUSC的数据协调部门(DCU)协调了40多个多中心
研究并将提供研究设计和信息技术支持以及数据管理支持
领导核心。置换的目的是:1)评估当前与指导方针之间的差距-
儿童SCD患者卒中预防的推荐做法,2)多水平评估
患者、提供者和系统阻碍执行TCD筛查和启动CRCT,以及3)
评估一种新的多层次传播和实施战略的有效性,以增加当前
采用平行整群随机临床试验的年度TCD筛查率和CRCT启动率。我们
汇聚了分布广泛的机构组成的大型多机构协作组织
以最佳方式评估多层次实施战略的可行性和实用性。的长期目标是
置换是为了确保所有患有SCD的儿童接受基于指南的中风预防护理
SCD中的“无卒中一代”。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ROBERT J ADAMS其他文献
ROBERT J ADAMS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ROBERT J ADAMS', 18)}}的其他基金
DISPLACE: Dissemination and Implementation of Stroke Prevention Looking at the Care Environment
DISPLACE:从护理环境来看中风预防的传播和实施
- 批准号:
10210281 - 财政年份:2017
- 资助金额:
$ 101.54万 - 项目类别:
Clinical & Translational Tools and Resources (CTTR) Core
临床
- 批准号:
10621739 - 财政年份:2014
- 资助金额:
$ 101.54万 - 项目类别:
Clinical & Translational Tools and Resources (CTTR) Core
临床
- 批准号:
10232065 - 财政年份:2014
- 资助金额:
$ 101.54万 - 项目类别:
Clinical and Translational Tools and Resources Core
临床和转化工具和资源核心
- 批准号:
8663382 - 财政年份:2014
- 资助金额:
$ 101.54万 - 项目类别:
Clinical & Translational Tools and Resources (CTTR) Core
临床
- 批准号:
10381594 - 财政年份:2014
- 资助金额:
$ 101.54万 - 项目类别:
Hydroxyurea to Prevent CNS Complications of Sickle Cell Disease in Children
羟基脲预防儿童镰状细胞病中枢神经系统并发症
- 批准号:
8322635 - 财政年份:2011
- 资助金额:
$ 101.54万 - 项目类别:
Prevention of Stroke after STOP, A Retrospective Chart Review
停止后预防中风,回顾性图表回顾
- 批准号:
7922143 - 财政年份:2009
- 资助金额:
$ 101.54万 - 项目类别:
Prevention of Stroke after STOP, A Retrospective Chart Review
停止后预防中风,回顾性图表回顾
- 批准号:
7699050 - 财政年份:2009
- 资助金额:
$ 101.54万 - 项目类别:
Prevention of Stroke after STOP, A Retrospective Chart Review
停止后预防中风,回顾性图表回顾
- 批准号:
8292038 - 财政年份:2009
- 资助金额:
$ 101.54万 - 项目类别:
相似海外基金
Hormone therapy, age of menopause, previous parity, and APOE genotype affect cognition in aging humans.
激素治疗、绝经年龄、既往产次和 APOE 基因型会影响老年人的认知。
- 批准号:
495182 - 财政年份:2023
- 资助金额:
$ 101.54万 - 项目类别:
Investigating how alternative splicing processes affect cartilage biology from development to old age
研究选择性剪接过程如何影响从发育到老年的软骨生物学
- 批准号:
2601817 - 财政年份:2021
- 资助金额:
$ 101.54万 - 项目类别:
Studentship
RAPID: Coronavirus Risk Communication: How Age and Communication Format Affect Risk Perception and Behaviors
RAPID:冠状病毒风险沟通:年龄和沟通方式如何影响风险认知和行为
- 批准号:
2029039 - 财政年份:2020
- 资助金额:
$ 101.54万 - 项目类别:
Standard Grant
Neighborhood and Parent Variables Affect Low-Income Preschool Age Child Physical Activity
社区和家长变量影响低收入学龄前儿童的身体活动
- 批准号:
9888417 - 财政年份:2019
- 资助金额:
$ 101.54万 - 项目类别:
The affect of Age related hearing loss for cognitive function
年龄相关性听力损失对认知功能的影响
- 批准号:
17K11318 - 财政年份:2017
- 资助金额:
$ 101.54万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
- 批准号:
9320090 - 财政年份:2017
- 资助金额:
$ 101.54万 - 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
- 批准号:
10166936 - 财政年份:2017
- 资助金额:
$ 101.54万 - 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
- 批准号:
9761593 - 财政年份:2017
- 资助金额:
$ 101.54万 - 项目类别:
How age dependent molecular changes in T follicular helper cells affect their function
滤泡辅助 T 细胞的年龄依赖性分子变化如何影响其功能
- 批准号:
BB/M50306X/1 - 财政年份:2014
- 资助金额:
$ 101.54万 - 项目类别:
Training Grant
Inflamm-aging: What do we know about the effect of inflammation on HIV treatment and disease as we age, and how does this affect our search for a Cure?
炎症衰老:随着年龄的增长,我们对炎症对艾滋病毒治疗和疾病的影响了解多少?这对我们寻找治愈方法有何影响?
- 批准号:
288272 - 财政年份:2013
- 资助金额:
$ 101.54万 - 项目类别:
Miscellaneous Programs














{{item.name}}会员




